Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  240,358 results for ""Etoposide""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer.

  • Authors : Liu J; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, People's Republic of China.; Tianjin Institute of Coloproctology, Tianjin, People's Republic of China.

Subjects: Etoposide*/Etoposide*/Etoposide*/pharmacology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Oct 10; Vol. 14 (1), pp. 23661. Date of Electronic Publication: 2024 Oct 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma.

  • Authors : Feng D; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; Yan Z

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2024 Dec; Vol. 29 (1), pp. 2402102. Date of Electronic Publication: 2024 Sep 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Hyaluronic acid-functionalized carboxymethyl dextran-coated melatonin nanoconjugates for targeted etoposide delivery in metastatic colon cancer: Extensive in-vitro investigation in HCT116 cell lines, antimicrobial efficacy, and anti-angiogenic potential in chick chorioallantoic membrane (CAM) assay.

  • Authors : Bhattacharya S; School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India. Electronic address: .; Raval H

Subjects: Hyaluronic Acid*/Hyaluronic Acid*/Hyaluronic Acid*/chemistry ; Hyaluronic Acid*/Hyaluronic Acid*/Hyaluronic Acid*/pharmacology ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 Nov; Vol. 281 (Pt 3), pp. 136373. Date of Electronic Publication: 2024 Oct 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer.

  • Authors : Huang S; Department of Gynecology and Obstetrics, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. .

Subjects: Etoposide*/Etoposide*/Etoposide*/administration & dosage ; Etoposide*/Etoposide*/Etoposide*/adverse effects ; Quinolines*/Quinolines*/Quinolines*/adverse effects

  • Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Nov; Vol. 35 (6), pp. e100. Date of Electronic Publication: 2024 Apr 22.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study.

  • Authors : Liu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.; He M

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/mortality

  • Source: BMC cancer [BMC Cancer] 2024 Oct 18; Vol. 24 (1), pp. 1290. Date of Electronic Publication: 2024 Oct 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia.

  • Authors : Gera K; Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.; Cline C

Subjects: Etoposide*/Etoposide*/Etoposide*/administration & dosage ; Etoposide*/Etoposide*/Etoposide*/adverse effects ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct; Vol. 65 (10), pp. 1502-1510. Date of Electronic Publication: 2024 Jun 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.

Subjects: Etoposide*/Etoposide*/Etoposide*/administration & dosage ; Etoposide*/Etoposide*/Etoposide*/adverse effects ; Ifosfamide*/Ifosfamide*/Ifosfamide*/administration & dosage

  • Source: JAMA oncology [JAMA Oncol] 2024 Dec 01; Vol. 10 (12), pp. 1645-1653.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.

  • Authors : Zhou H; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; National Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China.

Subjects: Indazoles*/Indazoles*/Indazoles*/administration & dosage ; Indazoles*/Indazoles*/Indazoles*/adverse effects ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Nov 04; Vol. 34 (11), pp. 1761-1767. DatePublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non-Small-Cell Lung Cancer.

  • Authors : Concannon KF; Department of Hematology/Onscology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Glisson BS

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage ; Etoposide*/Etoposide*/Etoposide*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Clinical lung cancer [Clin Lung Cancer] 2024 Nov; Vol. 25 (7), pp. 601-611. Date of Electronic Publication: 2024 Sep 01.Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.

  • Authors : Brown J; Atrium Health Levine Cancer, Wake Forest University Comprehensive Cancer Center, Charlotte, NC, United States of America. Electronic address: .; Miller A

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/administration & dosage

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Nov; Vol. 190, pp. 283-290. Date of Electronic Publication: 2024 Sep 12.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  240,358 results for ""Etoposide""